Primary Care Clinics in Hollywood, CA Accepting Medicare
3 Primary Care Clinics found. Showing 1 - 3
 St. Anthony Medical Centers Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 6368 Hollywood Blvd, Hollywood, CA 90028 Phone: 323-469-5555 |
Mission City Community Network, Inc. Clinic/Center - Community Health Medicare: Medicare Enrolled Practice Location: 4842 Hollywood Blvd, Hollywood, CA 90027 Phone: 323-644-1110 Fax: 323-644-1171 |
Bethany Towers Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 1745 N Gramercy Pl, Hollywood, CA 90028 Phone: 323-467-3121 Fax: 323-469-0627 |
News Archive
Despite USPSTF controversial recommendations, mammogram rate did not decline
More than three years after the United States Preventive Services Task Force (USPSTF) recommended against routine mammogram screening for women between the ages of 40 and 49, a study from Brigham and Women's Hospital (BWH) finds that mammogram rates in the United States have not declined in that age group, or any other. The study results are published in the April 19, 2013 online edition of the journal Cancer.
Young women veterans referred for cardiac tests more likely to be depressed than men veterans
Women veterans who had specialized heart tests were younger and more likely to be obese, depressed and suffer from post-traumatic stress disorder than men veterans, according to a study published in an American Heart Association journal.
Neuralstem's stem cell treatment for ALS featured on CNN with Dr. Sanjay Gupta
Neuralstem, Inc. announced that its stem cell treatment for ALS (Amyotrophic Lateral Sclerosis, or Lou Gehrig's disease), currently in a FDA-approved Phase I clinical trial, was featured on CNN last night with Dr. Sanjay Gupta, in the piece entitled "Stem Cell Medical Breakthrough".
Flow cytometry isolates stem cells from brain tumors
A new video protocol in Journal of Visualized Experiments (JoVE) details an assay to identify brain tumor initiating stem cells from primary brain tumors. Through flow cytometry, scientists separate stem cells from the rest of the tumor, allowing quick and efficient analysis of target cells. This approach has been effectively used to identify similar stem cells in leukemia patients.
BioInvent receives FDA IND clearance for BI-204 Phase II trial in cardiovascular disease
BioInvent International AB today announces IND clearance from the U.S. Food & Drug Administration (FDA) to initiate a Phase II study for BI-204. BI-204 is a human monoclonal antibody that specifically targets oxidized forms of a low-density lipoprotein (LDL) which has been linked to increased inflammatory processes leading to plaque formation in the blood vessel walls. BI-204 is being co-developed with Genentech for secondary prevention of cardiovascular events in patients with acute coronary syndrome (ACS).
› Verified 7 days ago